253 related articles for article (PubMed ID: 23957812)
1. LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.
Nukolova NV; Oberoi HS; Zhao Y; Chekhonin VP; Kabanov AV; Bronich TK
Mol Pharm; 2013 Oct; 10(10):3913-21. PubMed ID: 23957812
[TBL] [Abstract][Full Text] [Related]
2. Folate-decorated nanogels for targeted therapy of ovarian cancer.
Nukolova NV; Oberoi HS; Cohen SM; Kabanov AV; Bronich TK
Biomaterials; 2011 Aug; 32(23):5417-26. PubMed ID: 21536326
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
[TBL] [Abstract][Full Text] [Related]
4. Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta -aminoester)-graft-PEG for cancer chemotherapy.
Jin W; Xu P; Zhan Y; Shen Y; Van Kirk EA; Alexander B; Murdoch WJ; Liu L; Isaak DD
Drug Deliv; 2007 Jul; 14(5):279-86. PubMed ID: 17613015
[TBL] [Abstract][Full Text] [Related]
5. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer.
Xi X; Lei F; Gao K; Li J; Liu R; Karpf AR; Bronich TK
J Control Release; 2023 Aug; 360():872-887. PubMed ID: 37478915
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
7. Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells.
Gonzalez-Urias A; Zapata-Gonzalez I; Licea-Claverie A; Licea-Navarro AF; Bernaldez-Sarabia J; Cervantes-Luevano K
Colloids Surf B Biointerfaces; 2019 Oct; 182():110365. PubMed ID: 31344612
[TBL] [Abstract][Full Text] [Related]
8. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanogels: a versatile platform for drug delivery to tumors.
Murphy EA; Majeti BK; Mukthavaram R; Acevedo LM; Barnes LA; Cheresh DA
Mol Cancer Ther; 2011 Jun; 10(6):972-82. PubMed ID: 21518727
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of cisplatin from pH-thermal dual responsive nanogels.
Peng J; Qi T; Liao J; Chu B; Yang Q; Li W; Qu Y; Luo F; Qian Z
Biomaterials; 2013 Nov; 34(34):8726-40. PubMed ID: 23948167
[TBL] [Abstract][Full Text] [Related]
11. Platinum-Coordinated Dual-Responsive Nanogels for Universal Drug Delivery and Combination Cancer Therapy.
Duan QY; Zhu YX; Jia HR; Guo Y; Zhang X; Gu R; Li C; Wu FG
Small; 2022 Nov; 18(46):e2203260. PubMed ID: 36333101
[TBL] [Abstract][Full Text] [Related]
12. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
Bioconjug Chem; 2008 Nov; 19(11):2156-62. PubMed ID: 18850733
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
14. Design and engineering of nanogels for cancer treatment.
Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2011 May; 16(9-10):457-63. PubMed ID: 21414419
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Desale SS; Cohen SM; Zhao Y; Kabanov AV; Bronich TK
J Control Release; 2013 Nov; 171(3):339-48. PubMed ID: 23665258
[TBL] [Abstract][Full Text] [Related]
16. Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review.
Maya S; Sarmento B; Nair A; Rejinold NS; Nair SV; Jayakumar R
Curr Pharm Des; 2013; 19(41):7203-18. PubMed ID: 23489200
[TBL] [Abstract][Full Text] [Related]
17. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
[TBL] [Abstract][Full Text] [Related]
18. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilicity/Hydrophobicity reversable and redox-sensitive nanogels for anticancer drug delivery.
Yang H; Wang Q; Chen W; Zhao Y; Yong T; Gan L; Xu H; Yang X
Mol Pharm; 2015 May; 12(5):1636-47. PubMed ID: 25833093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
